Avricore Health Inc Share Price Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Sales 2021 | 123K 89.77K 7.49M | Sales 2022 | 1.77M 1.29M 108M | Capitalization | 31.26M 22.85M 1.91B |
---|---|---|---|---|---|
Net income 2021 | -1M -731K -60.98M | Net income 2022 | - 0 0 | EV / Sales 2021 | 111 x |
Net cash position 2021 | 1.97M 1.44M 120M | Net cash position 2022 | 591K 432K 36.01M | EV / Sales 2022 | 17.3 x |
P/E ratio 2021 |
-8.67
x | P/E ratio 2022 |
-37.7
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.31% |
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01/19/01 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06/19/06 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/20/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 20/16/20 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27/18/27 |
Christine Hrudka
BRD | Director/Board Member | - | 21/23/21 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |